Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOvoca Bio Regulatory News (OVB)

  • There is currently no data for OVB

Proposed Disposal

19 Nov 2008 07:00

RNS Number : 4408I
Ovoca Gold PLC
19 November 2008
 

Ovoca Gold plc ("Ovoca" or the "Company")

Disposal of CJSC "Prospectors Artel Ayax" ("Ayax")

The board of Ovoca announces that it has agreed to a proposed disposal of its wholly owned subsidiary Ayax, which has a 100% interest in the Goltsovoye silver deposit, to JSC Polymetal (the "Proposed Disposal"). JSC Polymetal is Russian based mining and production company with a listing on the London Stock Exchange, and on the RussiaMICEX and RTS exchanges. The consideration payable under the Proposed Disposal comprises a cash payment of US$11 million and 7.5 million JSC Polymetal ordinary shares which had a market price of USD2.67 as of the close of business on 18 November 2008In addition, a cash payment will be made to Ovoca in consideration for certain other ancillary assets and machinery equivalent to their book value. 

The Proposed Disposal is subject, inter alia, to agreeing detailed terms and conditions with JSC Polymetal, execution of legal agreements and the approval of Ovoca shareholders and the Russian Federal Antimonopoly Service.

Conditional on completion of the Proposed Disposal, it is the intention of the board of Ovoca to focus on the Company's exciting properties in the Kola Peninsula in Russia, including the Oleninskoye gold project and the Pellapakh molybdenum-copper ore field, and that the sale proceeds will be used to finance the exploration of these properties.

further announcement regarding the Proposed Disposal will be made in due course. 

For further information contact

Ovoca Gold plc

Mr. Danesh Varma CFO

+44 020 7653 9881 danesh.varma@ovocagold.com

Mr. Leonid Skoptsov CEO

+7 495 648 26 46

leonid.skoptsov@ovocagold.com

Davy

John Frain

+353 1 614 679 6363

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISUWRRRWKRAAUA
Date   Source Headline
29th Jul 20227:00 amRNSCompletion of Enrollment in Phase II Study
30th Jun 20227:00 amRNSAnnual Financial Report
7th Mar 20229:00 amRNSStatement re Russian Business Operations
23rd Feb 20224:41 pmRNSSecond Price Monitoring Extn
23rd Feb 20224:36 pmRNSPrice Monitoring Extension
22nd Feb 20223:30 pmRNSRussian Marketing Authorisation for Orenetide
31st Jan 20227:00 amRNSBoard Changes and Update
30th Dec 20217:00 amRNSDirectorate Change
4th Nov 20213:53 pmRNSHolding(s) in Company
4th Nov 20213:50 pmRNSDirector/PDMR Shareholding
4th Nov 20213:46 pmRNSBoard Change
14th Sep 20217:00 amRNSInterim Results
29th Jul 20215:00 pmRNSResult of AGM
24th Jun 20217:00 amRNSAnnual Report and Notice of AGM
10th Mar 20217:00 amRNSMigration of Participating Securities
16th Feb 20212:00 pmRNSResult of EGM
29th Jan 20217:00 amRNSFirst Patient Enrolled in Phase II Study - BP-101
25th Jan 20213:30 pmRNSNotice of EGM
5th Jan 20217:00 amRNSRe-Filing of Marketing Authorisation Application
17th Dec 20202:45 pmRNSResult of AGM
27th Nov 20203:08 pmRNSNotice of AGM
9th Oct 20207:00 amRNSAppointment of Chief Business Officer
2nd Oct 202011:06 amRNSSecond Price Monitoring Extn
2nd Oct 202011:00 amRNSPrice Monitoring Extension
2nd Oct 20209:05 amRNSSecond Price Monitoring Extn
2nd Oct 20209:00 amRNSPrice Monitoring Extension
2nd Oct 20207:00 amRNSUpdate re Russian Marketing Authorisation
28th Sep 20207:00 amRNSDeath of a Director
21st Sep 20207:00 amRNSInterim Results
14th Aug 202011:05 amRNSSecond Price Monitoring Extn
14th Aug 202011:00 amRNSPrice Monitoring Extension
26th Jun 20207:00 amRNSAnnual Report
14th Apr 20202:05 pmRNSSecond Price Monitoring Extn
14th Apr 20202:00 pmRNSPrice Monitoring Extension
24th Mar 20207:00 amRNSAcquisition of Remaining Minority Interest in IVIX
7th Nov 201912:45 pmRNSAttendance at Bio-Europe Conference
16th Sep 20197:00 amRNSInterim Results
12th Sep 20197:00 amRNSFiling of Marketing Authorisation Application
28th Aug 20197:00 amRNSDirectorate Change
8th Aug 20194:14 pmRNSResult of AGM
8th Aug 20199:05 amRNSSecond Price Monitoring Extn
8th Aug 20199:00 amRNSPrice Monitoring Extension
8th Aug 20197:00 amRNSAGM Statement
26th Jul 20197:00 amRNSDirectorate Change
25th Jul 20194:41 pmRNSSecond Price Monitoring Extn
25th Jul 20194:35 pmRNSPrice Monitoring Extension
28th Jun 20197:00 amRNSAnnual Report and Notice of AGM
23rd Apr 20197:00 amRNSUS and EU Clinical Development Plans
29th Mar 20197:00 amRNSDirector/PDMR Shareholding
27th Mar 20197:00 amRNSOperational Update & Additional Investment in IVIX

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.